Inhibikase Therapeutics Inc
IKT1.550USD
+0.030+1.97%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
115.23MMarket Cap
LossP/E TTM
Inhibikase Therapeutics Inc
1.550
+0.030+1.97%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
FY2018Q4
FY2018Q1
FY2017Q4
FY2017Q1
Total revenue
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%1.00
991.33%79.57K
1676.71%116.41K
40.17%64.52K
3169.86%63.57K
-97.78%7.29K
-99.52%6.55K
-96.73%46.03K
-98.86%1.94K
771.71%328.46K
520.73%1.36M
419.66%1.41M
-29.07%170.42K
-69.72%37.68K
31.54%219.59K
-54.19%270.79K
-82.14%240.28K
--124.43K
--166.93K
-14.48%591.10K
68.68%1.35M
179.41%691.20K
--797.40K
--247.38K
Revenue
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%1.00
991.33%79.57K
1676.71%116.41K
40.17%64.52K
3169.86%63.57K
-97.78%7.29K
-99.52%6.55K
-96.73%46.03K
-98.86%1.94K
771.71%328.46K
520.73%1.36M
419.66%1.41M
-29.07%170.42K
-69.72%37.68K
31.54%219.59K
-54.19%270.79K
-82.14%240.28K
--124.43K
--166.93K
-14.48%591.10K
68.68%1.35M
179.41%691.20K
--797.40K
--247.38K
Operating expenses
229.60%15.76M
193.60%12.93M
20.19%5.83M
-20.07%5.05M
0.06%4.78M
0.11%4.40M
7.26%4.85M
35.99%6.32M
1.98%4.78M
-12.79%4.40M
-5.82%4.52M
16.41%4.65M
16.22%4.69M
267.79%5.04M
584.28%4.80M
530.05%3.99M
397.34%4.03M
106.97%1.37M
-47.23%701.39K
-74.72%633.51K
-65.11%810.80K
-74.56%662.54K
--1.33M
--2.51M
188.93%2.32M
250.26%2.60M
88.50%804.27K
--743.49K
--426.67K
R&D expenses
282.13%10.51M
139.55%7.19M
29.90%4.19M
-32.19%3.08M
-3.60%2.75M
-1.68%3.00M
8.18%3.23M
52.09%4.54M
-5.40%2.85M
-9.91%3.05M
-5.48%2.98M
25.17%2.98M
24.06%3.02M
1393.87%3.39M
2516.39%3.15M
805.27%2.38M
758.97%2.43M
-15.29%226.94K
-52.71%120.57K
-44.48%263.18K
-81.80%283.11K
-81.66%267.92K
--254.97K
--474.05K
165.81%1.56M
143.47%1.46M
127.84%585.29K
--600.12K
--256.89K
Depreciation, depletion, and amortization
92.66%12.65K
-0.02%6.57K
-0.23%6.57K
-95.87%6.57K
30.24%6.57K
30.27%6.57K
291.61%6.58K
--159.20K
--5.04K
--5.04K
--1.68K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating profit
-229.60%-15.76M
-193.60%-12.93M
-22.20%-5.83M
18.57%-5.05M
-1.43%-4.78M
-1.58%-4.40M
-5.67%-4.77M
-33.67%-6.20M
-1.60%-4.71M
14.01%-4.33M
-0.94%-4.51M
-76.53%-4.64M
-76.77%-4.64M
-319.83%-5.04M
-573.64%-4.47M
-534.99%-2.63M
-386.15%-2.63M
-184.38%-1.20M
44.90%-663.71K
82.30%-413.92K
68.83%-540.01K
66.46%-422.26K
---1.20M
---2.34M
-1432.40%-1.73M
-2435.42%-1.26M
36.94%-113.07K
--53.91K
---179.29K
Net non-operating interest income (expenses)
Non-operating interest income
----
----
----
----
----
----
----
----
----
----
--18.54K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Special income (expenses)
--1.16M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income before tax
-194.19%-13.68M
-190.40%-12.13M
-25.74%-5.78M
14.16%-4.96M
-3.84%-4.65M
2.36%-4.18M
-2.24%-4.60M
-24.53%-5.78M
3.51%-4.48M
15.13%-4.28M
-0.52%-4.49M
-76.01%-4.64M
-75.98%-4.64M
-317.36%-5.04M
-566.75%-4.47M
-524.88%-2.64M
-381.71%-2.64M
-180.92%-1.21M
44.69%-670.60K
82.00%-421.87K
68.47%-547.44K
66.00%-430.01K
---1.21M
---2.34M
-1289.25%-1.74M
-2933.61%-1.26M
32.68%-124.98K
--44.63K
---185.65K
Income after tax
-194.19%-13.68M
-190.40%-12.13M
-25.74%-5.78M
14.16%-4.96M
-3.84%-4.65M
2.36%-4.18M
-2.24%-4.60M
-24.53%-5.78M
3.51%-4.48M
15.13%-4.28M
-0.52%-4.49M
-76.01%-4.64M
-75.98%-4.64M
-317.36%-5.04M
-566.75%-4.47M
-524.88%-2.64M
-381.71%-2.64M
-180.92%-1.21M
44.69%-670.60K
82.00%-421.87K
68.47%-547.44K
66.00%-430.01K
---1.21M
---2.34M
-1289.25%-1.74M
-2933.61%-1.26M
32.68%-124.98K
--44.63K
---185.65K
Net income from continuous operations
-194.19%-13.68M
-190.40%-12.13M
-25.74%-5.78M
14.16%-4.96M
-3.84%-4.65M
2.36%-4.18M
-2.24%-4.60M
-24.53%-5.78M
3.51%-4.48M
15.13%-4.28M
-0.52%-4.49M
-76.01%-4.64M
-75.98%-4.64M
-317.36%-5.04M
-566.75%-4.47M
-524.88%-2.64M
-381.71%-2.64M
-180.92%-1.21M
44.69%-670.60K
82.00%-421.87K
68.47%-547.44K
66.00%-430.01K
---1.21M
---2.34M
-1289.25%-1.74M
-2933.61%-1.26M
32.68%-124.98K
--44.63K
---185.65K
Net income attributable to controlling interests
-194.19%-13.68M
-190.40%-12.13M
-25.74%-5.78M
14.16%-4.96M
-3.84%-4.65M
2.36%-4.18M
-2.24%-4.60M
-24.53%-5.78M
3.51%-4.48M
15.13%-4.28M
-0.52%-4.49M
-76.01%-4.64M
-75.98%-4.64M
-317.36%-5.04M
-566.75%-4.47M
-524.88%-2.64M
-381.71%-2.64M
-180.92%-1.21M
44.69%-670.60K
82.00%-421.87K
68.47%-547.44K
66.00%-430.01K
---1.21M
---2.34M
-1289.25%-1.74M
-2933.61%-1.26M
32.68%-124.98K
--44.63K
---185.65K
Net income attributable to common shareholders
-194.19%-13.68M
-190.40%-12.13M
-25.74%-5.78M
14.16%-4.96M
-3.84%-4.65M
2.36%-4.18M
-2.24%-4.60M
-24.53%-5.78M
3.51%-4.48M
15.13%-4.28M
-0.52%-4.49M
-76.01%-4.64M
-75.98%-4.64M
-317.36%-5.04M
-566.75%-4.47M
-524.88%-2.64M
-381.71%-2.64M
-180.92%-1.21M
44.69%-670.60K
82.00%-421.87K
68.47%-547.44K
66.00%-430.01K
---1.21M
---2.34M
-1289.25%-1.74M
-2933.61%-1.26M
32.68%-124.98K
--44.63K
---185.65K
Basic earnings per share
79.17%-0.15
-10.81%-0.75
24.37%-0.65
40.47%-0.66
24.91%-0.73
33.37%-0.68
19.53%-0.86
-0.18%-1.11
11.59%-0.98
15.23%-1.02
-0.24%-1.07
-75.36%-1.10
29.81%-1.10
-37.50%-1.20
-117.31%-1.07
-74.15%-0.63
-348.44%-1.57
-336.93%-0.87
44.81%-0.49
82.01%-0.36
68.47%-0.35
75.03%-0.20
---0.89
---2.01
-1224.27%-1.11
-2772.40%-0.80
32.68%-0.08
--0.03
---0.12
Diluted earnings per share
79.17%-0.15
-10.81%-0.75
24.37%-0.65
40.47%-0.66
24.91%-0.73
33.37%-0.68
19.53%-0.86
-0.18%-1.11
11.59%-0.98
15.23%-1.02
-0.24%-1.07
-75.36%-1.10
29.81%-1.10
-37.50%-1.20
-117.31%-1.07
-74.15%-0.63
-348.44%-1.57
-336.93%-0.87
44.81%-0.49
82.01%-0.36
68.47%-0.35
75.03%-0.20
---0.89
---2.01
-1224.27%-1.11
-2772.40%-0.80
32.68%-0.08
--0.03
---0.12
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
